Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
Spinal muscle atrophy (SMA) is a devastating disease that is characterized by loss of motor neuron function and subsequent muscle weakness and atrophy. The disease results from deletion of survival of motor neuron 1 (SMN1) and SMN protein deficiency.
In humans, a duplication SMN1, SMN2 results in a truncated SMN protein; however, the number of SMN2 copies inversely correlates to disease severity. Disease onset occurs shortly after birth following a short period of normal muscle function.
In this issue of the Journal of Clinical Investigation, Umrao Monani and colleagues at Columbia University demonstrate in a mouse model that the timing of SMN depletion during development is critical to the pathogenesis of disease. Depletion of SMN in the early neonatal period resulted in an SMA-like phenotype, while depletion of SMN in mature mice had no effect.
In an accompanying Commentary, Kathryn Swoboda of the University of Utah discusses the implications of a temporal requirement of SMN for optimization of SMN repletion-based therapy.
ACCOMPANYING COMMENTARY TITLE: SMN-targeted therapeutics for spinal muscular atrophy: are we SMArt enough yet?
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our Neurology / Neuroscience category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
Journal of Clinical Investigation. "Spinal muscular atrophy development in mice influenced by timing of protein depletion." Medical News Today. MediLexicon, Intl., 29 Jan. 2014. Web.
24 Apr. 2014. <http://www.medicalnewstoday.com/releases/271796>
Journal of Clinical Investigation. (2014, January 29). "Spinal muscular atrophy development in mice influenced by timing of protein depletion." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/271796.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2014 All rights reserved. MNT is the registered trade mark of MediLexicon International Limited.